Developing an antibody-binding protein cage as a molecular recognition drug modular nanoplatform
Cited 15 times inCited 13 times in
- Developing an antibody-binding protein cage as a molecular recognition drug modular nanoplatform
- Kang, Hyo Jin; Kang, Young Ji; Lee, Young-Mi; Shin, Hyun-Hee; Chung, Sang J.; Kang, Sebyung
- Antibody-binding; Delivery platform; Fc-binding peptide; Molecular recognition; Protein cages
- Issue Date
- ELSEVIER SCI LTD
- BIOMATERIALS, v.33, no.21, pp.5423 - 5430
- We genetically introduced the Fc-binding peptide (FcBP) into the loop of a self-assembled protein cage, ferritin, constituting four-fold symmetry at the surface to use it as a modular delivery nanoplatform. FcBP-presenting ferritin (FcBP-ferritin) formed very stable non-covalent complexes with both human and rabbit IgGs through the simple molecular recognition between the Fc region of the antibodies and the Fc-binding peptide clusters inserted onto the surface of FcBP-ferritin. This approach realized orientation-controlled display of antibodies on the surfaces of the protein cages simply by mixing without any complicated chemical conjugation. Using trastuzumab, a human anti-HER2 antibody used to treat patients with breast cancer, and a rabbit antibody to folate receptor, along with fluorescently labeled FcBP-ferritin, we demonstrated the specific binding of these complexes to breast cancer cells and folate receptor over-expressing cells, respectively, by fluorescent cell imaging. FcBP-ferritin may be potentially used as modular nanoplatforms for active targeted delivery vehicles or molecular imaging probes with a series of antibodies on demand.
- ; Go to Link
Appears in Collections:
- SLS_Journal Papers
can give you direct access to the published full text of this article. (UNISTARs only)
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.